J. C. A. van Meel

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

Wolfgang Wienen, Norbert Hauel, J. C. A. van Meel et al. · British Journal of Pharmacology · 1993 · 192 citations · Full text

Hypertension, Pharmacological Characterization, Cardiovascular Pharmacology +19

Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptor activation is induced by an influx of extracellular calcium

J. C. A. van Meel, A. de Jonge, Hans O. Kalkman et al. · European Journal of Pharmacology · 1981 · 158 citations

Muscle Physiology, Muscle Function, Molecular Physiology +13

Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α 2-Adrenoceptors

J. C. A. van Meel, A. de Jonge, Hans O. Kalkman et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1981 · 135 citations

Molecular Pharmacology, Adrenal Gland, Sodium Homeostasis +7

A lipophilic, selective α1 -adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587)

A. de Jonge, J. C. A. van Meel, Pieter B.M.W.M. Timmermans et al. · Life Sciences · 1981 · 103 citations

Molecular Pharmacology, Biochemistry, Medicine +9

Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds

Marlene Dengg, J. C. A. van Meel · Journal of Pharmacological and Toxicological Methods · 2004 · 95 citations

Rapid Toxicity Assessment, Predictive Toxicology, Biochemistry +10